Cytosorbents Corp
CTSO
33 hedge funds and large institutions have $5.02M invested in Cytosorbents Corp in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 8 closing their positions.
901% more call options, than puts
Call options by funds: $751K | Put options by funds: $75K
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
13% less funds holding
Funds holding: 38 → 33 (-5)
34% less capital invested
Capital invested by funds: $7.66M → $5.02M (-$2.64M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$336K |
| 2 |
AIG
American International Group
New York
|
+$117K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$105K |
| 4 |
Bank of New York Mellon
New York
|
+$48K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$47.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$153K |
| 2 |
Goldman Sachs
New York
|
-$128K |
| 3 |
Blackstone Inc
New York
|
-$112K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$112K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$78K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $5K | -$6.63K | -1,528 | -51% |
|
|
BA
27
BlackRock Advisors
Wilmington,
Delaware
| $3K | – | – | – |
|
|
HF
28
Hoxton Financial
Shepherdstown,
West Virginia
| $3K | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
JG
30
Jefferies Group
New York
| $2K | – | – | – |
|
31
Citigroup
New York
| $1K | +$725 | +167 | New |
|
32
Geode Capital Management
Boston,
Massachusetts
| $493 | -$438 | -101 | -0.1% |
|
|
33
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$153K | -27,400 | Closed |
|
|
34
Goldman Sachs
New York
| – | -$128K | -22,941 | Closed |
|
|
35
Blackstone Inc
New York
| – | -$112K | -20,118 | Closed |
|
|
VKH
36
Virtu KCG Holdings
New York
| – | -$112K | -20,021 | Closed |
|
|
ARTA
37
A.R.T. Advisors
New York
| – | -$78K | -14,033 | Closed |
|
|
BCM
38
Bluefin Capital Management
New York
| – | -$77K | -13,755 | Closed |
|
39
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$43.4K | -10,003 | -99% |
|
|
IA
40
IFP Advisors
Tampa,
Florida
| – | -$31K | -5,600 | Closed |
|
|
CG
41
Cutler Group
San Francisco,
California
| – | -$1.74K | -400 | Closed |
|
CTSO Hedge Fund Activity: Q1 2016 in Review
33 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2016, worth a combined $5.02M — down 34% from $7.66M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CTSO and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 10 added.
The largest buyer was Raymond James & Associates, opening a new position worth an estimated $336K. The largest seller was Bank of Montreal, exiting entirely with an estimated $153K sold.
- 33 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2016, down from 38 in Q4 2015.
- Funds reported $5.02M of Cytosorbents Corp stock for Q1 2016, down 34% quarter-over-quarter.
- 3 funds opened new Cytosorbents Corp positions in Q1 2016 and 8 closed out, a net change of -5 holders.
- The largest Cytosorbents Corp buyer in Q1 2016 was Raymond James & Associates, an estimated $336K added.
- The largest Cytosorbents Corp seller in Q1 2016 was Bank of Montreal, an estimated $153K sold.
Based on aggregated 13F filings for Q1 2016.